Medtech

Brainomix Technology Integrated into New UK Atrial Fibrillation Study

Retrieved on: 
Wednesday, February 22, 2023
Atrial fibrillation, University, Post-stroke depression, Patient, Medtech, AF, Research, Risk, AI, NHS, Stroke, Innovation, Oxford, Pharmaceutical industry

OXFORD, England, Feb. 22, 2023 /PRNewswire/ -- Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF).

Key Points: 
  • OXFORD, England, Feb. 22, 2023 /PRNewswire/ -- Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF).
  • The Liverpool-Huawei Stroke Study aims to determine the clinical effectiveness, cost effectiveness, and acceptability of Huawei Smartwear to detect AF in patients following an acute ischemic stroke.
  • Atrial fibrillation is a common heart rhythm disorder which increases the risk of stroke five-fold and is estimated to affect 24% of post-stroke patients.
  • As an Oxford-based AI-powered MedTech company, Brainomix is highly supportive of this type of innovative research activity in the UK.

Brainomix Technology Integrated into New UK Atrial Fibrillation Study

Retrieved on: 
Wednesday, February 22, 2023
Atrial fibrillation, University, Post-stroke depression, Patient, Medtech, AF, Research, Risk, AI, NHS, Stroke, Innovation, Oxford, Pharmaceutical industry

OXFORD, England, Feb. 22, 2023 /PRNewswire/ -- Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF).

Key Points: 
  • OXFORD, England, Feb. 22, 2023 /PRNewswire/ -- Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF).
  • The Liverpool-Huawei Stroke Study aims to determine the clinical effectiveness, cost effectiveness, and acceptability of Huawei Smartwear to detect AF in patients following an acute ischemic stroke.
  • Atrial fibrillation is a common heart rhythm disorder which increases the risk of stroke five-fold and is estimated to affect 24% of post-stroke patients.
  • As an Oxford-based AI-powered MedTech company, Brainomix is highly supportive of this type of innovative research activity in the UK.

Inspire Agency Grows with DPX Technologies Win

Retrieved on: 
Tuesday, February 21, 2023
Biology, Medicine, Medtech, SC, University, DPX, Marketing, Growth, Health, Chemistry, Catalent, Conference, Social media, Columbia, Mental health, Management, Inspiration

CHARLESTON, S.C., Feb. 21, 2023 /PRNewswire/ -- Inspire Agency, a full-service branding and content agency providing inspiring brand development, content marketing, media relations and corporate communications, announced today that it has added DPX Technologies to its growing roster of world-class clients. Inspire works across a variety of industries and specializes in life sciences, medtech, healthcare and mental health. Cutting-edge DPX offers creative solutions for complex sample preparation and is committed to quality, speed and continual improvement.

Key Points: 
  • CHARLESTON, S.C., Feb. 21, 2023 /PRNewswire/ -- Inspire Agency , a full-service branding and content agency providing inspiring brand development , content marketing , media relations and corporate communications , announced today that it has added DPX Technologies to its growing roster of world-class clients.
  • Inspire works across a variety of industries and specializes in life sciences, medtech, healthcare and mental health.
  • Cutting-edge DPX offers creative solutions for complex sample preparation and is committed to quality, speed and continual improvement.
  • "As DPX looks to empower more scientists with our versatile, innovative products and solve more complex problems with chemistry and now biology, we've chosen to team with Inspire Agency as the experienced life sciences agency we need to help accelerate our growth in the pharmaceuticals and genomics sectors," said Dr. William Brewer, Chief Executive and Chief Scientific Officer of DPX Technologies.

ACROMETA Acquires Controlling Stake in Co-Working Lab Space Company Life Science Incubator (LSI)

Retrieved on: 
Monday, February 20, 2023
DNA, Laboratory, German Centre for Rail Traffic Research, LSI, Media release, Medtech, Engineering, Research, SME, LOI, Health care, Partnership, Growth, Confidentiality, Dream, SGX, R, Airline, Fine chemical, Renewable energy, Biotechnology, Biopharma LLC

LSI currently operates a 6,500 sq feet co-working laboratory space at The German Centre in Singapore serving SMEs and start-ups.

Key Points: 
  • LSI currently operates a 6,500 sq feet co-working laboratory space at The German Centre in Singapore serving SMEs and start-ups.
  • Launched in September 2021, LSI at German Centre garners very healthy occupancy rates within a year of operations.
  • The additional stake will add another dimension of growth to the Group's business as it becomes not only a builder of laboratories but also an operator of co-working laboratory space.
  • "This potentially carves out a new promising mainstream business for us as controlled environment specialist", says ACROMETA Executive Chairman, Mr Levin Lee Keng Weng.

Alpha Tau to Participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference

Retrieved on: 
Tuesday, February 21, 2023
Citigroup, Alpha Sigma Tau, Conference, Alpha, Pharmaceutical industry, Plumbing, Gutta-percha, Medtech

JERUSALEM, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 1, 2023 taking place at Citi HQ Conference Center in New York City.

Key Points: 
  • JERUSALEM, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to participate in Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference on March 1, 2023 taking place at Citi HQ Conference Center in New York City.
  • If you would like to schedule a 1:1 meeting, please contact your Citi representative.

Canadian Startup Makes Major Breakthrough in Its Mission to Create the Next Generation of AI

Retrieved on: 
Tuesday, February 14, 2023
Sustainable Development Technology Canada, Deep learning, AGI, Artificial general intelligence, SEED, Neuroscience, Entrepreneurship, Face, Workforce, Engineering, Research, SME, Government, Student, IP, Medtech, Machine learning, Environment, Solid, Robotics, AI, Medical device, Mind

"With the growing labor shortage, this additional help is not only desirable but soon to be essential."

Key Points: 
  • "With the growing labor shortage, this additional help is not only desirable but soon to be essential."
  • Solid State of Mind introduces Deep MeaningTM, a new AI approach generating foundational knowledge that generalizes across any environment.
  • "In stark contrast, our Deep MeaningTM AI technology adapts very quickly to such superficial changes, more like a human would."
  • Overall, Solid State of Mind's AI adapted to new environments using 10,000x less trials and 100,000x less energy than state-of-the-art AI.

United States Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market to 2031 - Featuring Canon, FUJIFILM Holdings, General Electric and Johnson & Johnson Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, February 20, 2023
Medical Devices, Health, Canon Inc., MRI, Acquisition, Johnson & Johnson, Incidence, Face, Artificial intelligence, POC, GE, GE HealthCare, General Electric Company, Magnetic resonance imaging, Fujifilm, Medtech, DePuy Synthes, MIS, Medical device, Dentistry, Medical imaging, Health care

The "U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User - Analysis and Forecast, 2022-2031" report has been added to ResearchAndMarkets.com's offering.
  • The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market is segmented into U.S. orthopedic imaging modalities market and U.S. orthopedic surgical navigation systems market.
  • On the other hand, the U.S. orthopedic surgical navigation systems market is in the developing phase.
  • Recent Developments in the U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market
    In February 2022, FUJIFILM Holdings Corporation launched the Sonosite LX ultrasound system.

Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference

Retrieved on: 
Friday, February 17, 2023
Medical Devices, Medical Supplies, Hospitals, Clinical Trials, Health Technology, Biotechnology, Health, Pharmaceutical, General Health, Research, Bio-Rad Laboratories, NYSE, Conference, Medtech, Pharmaceutical industry

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time).

Key Points: 
  • Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference on Thursday, March 2, 2023, at 11:45 AM Eastern Time (8:45 AM Pacific Time).

Guardant Health to Participate in Upcoming March Investor Conferences

Retrieved on: 
Friday, February 17, 2023
Oncology, Health, Health Technology, Other Science, Science, Biotechnology, Fireside chats, Conference, GH, Medtech, Cryptocurrency

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.

Key Points: 
  • Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences.
  • Citi 2023 Healthcare Services, MedTech, Tools & HCIT Conference in New York City, NY
    Fireside Chat on Wednesday, March 1st at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time
    Cowen 43rd Annual Health Care Conference in Boston, MA
    Fireside Chat on Wednesday, March 8th at 10:30 a.m. Eastern Time / 7:30 a.m. Pacific Time
    Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com .

GE HealthCare Leaders to Present at March Investor Conferences

Retrieved on: 
Thursday, February 16, 2023
Medical Supplies, Health, Medical Devices, Health Technology, Other Health, General Health, Biotechnology, CFO, Conference, GE, ET, GE HealthCare, Video game, Medtech

GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, is announcing today that its President and CEO Peter Arduini, along with Vice President and CFO Helmut Zodl, will be presenting at the following investor conferences next month.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, is announcing today that its President and CEO Peter Arduini, along with Vice President and CFO Helmut Zodl, will be presenting at the following investor conferences next month.
  • Citi’s 2023 Healthcare Services, Medtech, Tools & HCIT Conference - March 1, 2023 at 12:30 pm ET in New York City
    Oppenheimer 33rd Annual Healthcare Conference - March 14, 2023 at 10:00 am ET; this will be a virtual event
    These events can be accessed live by visiting GE HealthCare’s Investor Relations website: https://investor.gehealthcare.com/news-events/events at the dates and times listed above.